Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Company news
Company news
Novel compounds with antiviral activity from ChemDiv Collection
Institute of Virology, Hannover Medical School, reported about notable results in their drug discovery projects, using small molecule libraries designed and provided by ChemDiv Inc.
Meet ChemDiv,Inc at the Discovery on Target, 2023
Discovery on Target (DOT) conference will be held on September 25-28, 2023. It highlights advances in current and emerging “hot” targets and technologies
ChemDiv shares an update on its Cutting-edge Biology Facility in Portugal.
Coimbra, Portugal - ChemDiv Inc, a global leader in drug discovery and drug development solutions, shares the progress in the development of its cutting-edge biology facility at Biocant Park
Join ChemDiv,Inc at the International Helmholtz Drug Discovery Conference (HDDC)
Join ChemDiv,Inc at the International Helmholtz Drug Discovery Conference (HDDC) 2023 that will take place in Germany www.helmholtz-hzi.de/de/hddc2023 (May 15 to 16, 2023 – Braunschweig, Germany...
Join ChemDiv,Inc at CHI Drug Discovery Chemistry
Roman Timakhov, M.D., Ph.D, Research Director, ChemDiv Inc presented "First Principle Concept in Designing Small Molecules for Targeting RNA Expansion Repeats”
Happy Holidays 2023
The warmest congratulations on The New Year and Christmas from San Diego
ChemDiv and Jacobs University Announce Strategic Partnership in Drug Discovery
A new dedicated research group will be created on the Jacobs University Bremen campus, merging ChemDiv’s extensive drug discovery expertise and technological platforms with advanced fundamental rese...
ChemDiv Inc statement on impact of Russia military actions in Ukraine.
To our pharma and biotech customers and suppliers, we want to assure you that ChemDiv Inc is keenly aware of and strongly opposed to the current Russia military actions in Ukraine. ChemDiv Inc is a ...
We made a chemistry game for you. Have fun and enjoy it!
We made a chemistry game for you. Have fun and enjoy it!
ChemDiv is now a Discovery Partner with Gwynant Therapeutics and Celyn Therapeutics
ChemDiv has been selected as a discovery partner with Gwynant Therapeutics and Celyn Therapeutics and starts to work on novel small molecules for oncology targets. See all the details in PR...
ChemDiv at the international symposium on medicinal chemistry
The XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2021) will be held virtually, from August 29 to September 2, 2021. We present the following poster: BEYOND BINAR...
Visit our virtual booth at the European Chemical Biology Symposium
The virtual European Chemical Biology Symposium ECBS2021 is co-organised by the EuChemS Division “Chemistry in Life Sciences” (LS-EuChemS) and EU-OPENSCREEN ERIC and brings together scientists fro...
1
2
3
4
5
6
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds